The stock is in a moderate uptrend over the past year, with a 1-year price change of +11.56%, though it has underperformed the S&P 500's 19.1% gain. Currently trading at $41.87, it sits at 72.5% of its 52-week range (low $35.60, high $46.76), indicating it is closer to the upper end but not overextended. This positioning suggests a recovery from earlier lows but still below the highs, implying room for further upside if momentum persists. Short-term momentum is strong, with a 1-month price change of +12.77% and a 3-month change of +3.66%, showing acceleration from the 6-month decline of -3.24%. The 1-month relative strength of +14.02 versus the S&P 500 indicates recent outperformance, diverging from the 1-year relative weakness of -7.54, which could signal a potential trend reversal or mean reversion. The stock's beta of 0.63 indicates it is 37% less volatile than the market, making it a lower-risk holding. Key support lies near the 52-week low of $35.60, while resistance is at the 52-week high of $46.76. A breakout above $46.76 would signal a resumption of the longer-term uptrend, while a breakdown below $35.60 could indicate further downside. The low beta suggests limited downside risk relative to the broader market.

Revenue growth has been steady, with estimated annual revenue of $10.59 billion for the current fiscal year, though specific quarterly figures are not provided. The company's net margin of 10.30% indicates solid profitability, and the operating margin of 13.02% reflects efficient underwriting. Gross margin of 50.35% is typical for insurers, driven by premium income. Net income is positive, with an EPS of $0.084 (likely quarterly), and the trailing PE of 11.9x suggests the market values earnings reasonably. Profitability is robust, with a net margin of 10.30% and operating margin of 13.02%, both stable for the insurance industry. The ROE of 15.83% is strong, indicating effective capital utilization, while ROA of 2.95% is moderate. The company is profitable and generates consistent earnings, supporting its high dividend payout. The balance sheet is healthy, with a debt-to-equity ratio of 0.27, indicating low leverage, and a current ratio of 3.40, showing ample liquidity. Free cash flow is not directly provided, but the PCF ratio of 9.56 suggests strong cash generation relative to price. The low debt levels and high liquidity imply minimal financial risk, and the company likely funds its dividend and operations internally.